InPharm - Sales and Marketing News

Advisory committee votes in favour of AstraZeneca's thrombosis drug

But Genzyme merger still on the cards

Report ranks UK 12 out of the 14 countries surveyed

Cladribine could reach US market by early 2011

Final recommendations green light to Xeloda, Iressa and MabThera

Interim measure operational from October

Reportedly has informal approach from the French pharma firm

FDA approves Sandoz's version of the blockbuster anti-clotting drug

CHMP recommends new indication for anti-clotting drug be approved

Posts low sales growth on back of US health reform and European cost cutting